Search research articles
Contact Us
Filters
Showing results (51-60 of 166) with videos related to
Page
of 17
Sort By:
Annals of Surgical Oncology
|
October 30, 2015
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy
Shannon K Swisher, Jose Vila, Susan L Tucker, et al.
Sleep & Breathing = Schlaf & Atmung
|
September 3, 2024
Sleep disturbances based on patient reported outcomes in patients with breast cancer
Saadia A Faiz, Ashley S Knox, Bryan Fellman, et al.
Cancer
|
February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 years
Beth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
Oncotarget
|
March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer
Haven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Annals of Surgical Oncology
|
May 7, 2014
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing
Nisreen Elsayegh, Henry M Kuerer, Heather Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
T Fujii, T Kogawa, W Dong, et al.
Breast Disease
|
June 4, 2010
Wound complications from surgery in pregnancy-associated breast cancer (PABC)
Laura S Dominici, Henry M Kuerer, Gildy Babiera, et al.
Clinical Breast Cancer
|
December 15, 2010
Sentinel lymph node dissection is technically feasible in older breast cancer patients
Vicente Valero, Amanda L Kong, Kelly K Hunt, et al.
Oncotarget
|
September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
Elizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Annals of Surgical Oncology
|
May 31, 2013
Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy
David C Weksberg, Pamela K Allen, Karen E Hoffman, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 166) with videos related to
Sort By:
Page
of 17
Annals of Surgical Oncology
|
October 30, 2015
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy
Shannon K Swisher, Jose Vila, Susan L Tucker, et al.
Sleep & Breathing = Schlaf & Atmung
|
September 3, 2024
Sleep disturbances based on patient reported outcomes in patients with breast cancer
Saadia A Faiz, Ashley S Knox, Bryan Fellman, et al.
Cancer
|
February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 years
Beth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
Oncotarget
|
March 19, 2024
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer
Haven R Garber, Sreyashi Basu, Sonali Jindal, et al.
Annals of Surgical Oncology
|
May 7, 2014
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing
Nisreen Elsayegh, Henry M Kuerer, Heather Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
T Fujii, T Kogawa, W Dong, et al.
Breast Disease
|
June 4, 2010
Wound complications from surgery in pregnancy-associated breast cancer (PABC)
Laura S Dominici, Henry M Kuerer, Gildy Babiera, et al.
Clinical Breast Cancer
|
December 15, 2010
Sentinel lymph node dissection is technically feasible in older breast cancer patients
Vicente Valero, Amanda L Kong, Kelly K Hunt, et al.
Oncotarget
|
September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
Elizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Annals of Surgical Oncology
|
May 31, 2013
Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy
David C Weksberg, Pamela K Allen, Karen E Hoffman, et al.
Page
of 17